Suicidal thoughts can be aroused due to various underlying factors such as financial burden, social issues or drug side effects. Treatment for suicidal thoughts includes psychotherapy, medications, addiction treatment, and family support. Anti-depressants and anti-psychotics are the most widely used medications for treating suicidal tendencies. According to the World Health Organization (WHO), over 800,000 people die due to suicide annually. Development of an effective anti-suicidal drug could be a major breakthrough in reducing the death toll.
Get Sample Copy At: https://www.coherentmarketinsights.com/insight/request-sample/10
Market Dynamics
Off-label use of these drugs for suicidal ideation has been a practice for years, as there are no approved anti-suicide specific drug yet. However, the dynamics is expected to change in the following few years with the launch of first oral therapeutic drug for acute suicidal ideation. This would disrupt the use of antidepressants and anti-psychotic drugs for the treatment of suicidal tendencies. Suicidal incidences are high in low and middle income countries according to the WHO 2016 statistics.
Key features of the study:
-
This report provides in-depth analysis of the anti-suicide drugs and provides market size (US$ Million) and Cumulative Annual Growth Rate (CAGR (%)) for the forecast period: 2019 – 2027, considering 2018 as the base year
-
It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
-
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by the leading players
Detailed Segmentation:
-
Global Anti-Suicide Drugs Market, By Drug Class:
-
Anti-Depressants and Anti-Anxiety Drugs
-
Anti-Psychotic Drugs
-
NMDA Antagonist
-
Antibiotic Analog
-
-
Global Anti-Suicide Drugs Market, By Geography:
-
North America
-
U.S.
-
U.S. Anti-Suicide Drugs Market, By Drug Class:
-
Anti-Depressant and Anti-Anxiety Drugs
-
Anti-Psychotic Drugs
-
NMDA Antagonist
-
Antibiotic Analog
-
-
-
-
Key Players included in the Anti-Suicide Drugs Market:
Pfizer, Inc., AstraZeneca plc, Eli Lilly and Company, Allergan plc, GlaxoSmithKline plc, Merck & Co., Inc., H. Lundbeck A/S, NeuroRx, Inc., and Johnson & Johnson.
Anti-Suicide Drugs Market Regional Analysis:
In the report, the geographical outlook of the Anti-Suicide Drugs report is segmented into regions like North America, Latin America, Asia-Pacific, Europe, and Middle East & Africa.
Some of the important questions addressed in the report are:
-
What factors drive the market’s growth?
-
What will be the market size in 2028?
-
What is the expected market growth rate during the forecast period?
-
What was the market size of Anti-Suicide Drugs in 2020?
In which region will the Market have the largest market share?
About Coherent Market Insights
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.
Contact Us
Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Phone: US +12067016702 / UK +4402081334027
Email: sales@coherentmarketinsights.com
